Filing Details
- Accession Number:
- 0001178913-18-003093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 06:09:21
- Reporting Period:
- 2018-11-26
- Accepted Time:
- 2018-12-06 06:09:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1606645 | Foamix Pharmaceuticals Ltd. | FOMX | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1625184 | Aharon Schwartz | C/O Foamix Pharmaceuticals Ltd. 2 Holtzman Street Rehovot L3 7670402 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2018-11-26 | 50,000 | $3.89 | 50,000 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2018-11-27 | 50,000 | $3.92 | 100,000 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2018-11-28 | 12,200 | $3.88 | 112,200 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |